Status:

COMPLETED

Spectralis OCT Repeatability and Reproducibility Study

Lead Sponsor:

Heidelberg Engineering GmbH

Conditions:

Glaucoma

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

This single-center, prospective, interventional clinical study is conducted to evaluate the repeatability and reproducibility of structural parameters of the optic nerve head, the peripapillary retina...

Detailed Description

The study will include approximately 15 normal subjects and approximately 15 subjects who have glaucoma of varying degree. All subjects will undergo Spectralis OCT imaging and other study procedures i...

Eligibility Criteria

Inclusion

  • Subject is not an employee of the eye clinic.
  • Age ≥18
  • Able and willing to undergo the test procedures, give consent, and to follow instructions.
  • For "normal subjects": Healthy eye without prior intraocular surgery (except cataract surgery and Lasik - laser-assisted refractive surgery) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve.
  • For "glaucoma subjects": Early to advanced glaucoma according to existing medical charts.
  • Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.
  • When both eyes are eligible, one randomly selected eye will enter the study.

Exclusion

  • • Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:
  • Retina completely included in image frame,
  • Quality Score ≥ 20 in the stored ART mean images

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2013

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT02209077

Start Date

June 1 2013

End Date

July 1 2013

Last Update

August 5 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Ophthalmology and Visual Sciences, Dalhousie University

Halifax, Nova Scotia, Canada, B3H 2Y9